Kandera

Biography

KANDERA, Hookipa´s Chief Financial Officer, works with other senior managers to forecast best development paths and drive various funding initiatives. Reinhard has more than 20 years´ experience in the finance and healthcare industries. Immediately prior to joining Hookipa, he was a Member of the Management Board and CFO of Valneva SE, a commercial stage biotech vaccine company, listed on the Euronext Paris and the Vienna Stock Exchange. Prior to his role at Valneva, he was CFO and member of the Management Board of Intercell AG, another publicly listed European biotech company, which was merged with Vivalis SA to become Valneva in 2013. Before becoming Intercell’s CFO, Reinhard Kandera held various other positions at Intercell, including Global Head of Finance, and Investor Relations and CFO of Intercell USA (the formerly NASDAQ-listed Iomai Corporation). Reinhard played a pivotal role in the IPO of Intercell in 2005, multiple public and private financings exceeding hundreds of millions of euros/dollars, the acquisition and integration of businesses in Scotland, the USA, Switzerland and Sweden as well as the European cross-border merger that created Valneva. Reinhard Kandera started his career in the finance industry at Deutsche Bank AG where he held positions with increasing responsibility. He holds doctorate degrees in Business Administration and in Law from the Vienna University of Economics and Business, and the Vienna University’s Faculty of Law, respectively.

Research Interest

Immunology